RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center
|
|
|
- Scott Little
- 5 years ago
- Views:
Transcription
1 RHEUMATOLOGY OVERVIEW Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center
2 What is Rheumatology? Medical science devoted to the rheumatic diseases and musculoskeletal disorders Study of : autoimmune diseases connective tissue disease Template copyright
3 Inflammatory vs Non-inflammatory Erythema Warmth Pain Swelling Prolonged stiffness Systemic symptoms Mechanical pain (worse with activity) Improves with rest Stiffness after brief periods of rest (not prolonged) Absence of systemic signs Laboratory abnormalities
4 Differential Diagnosis for Different Joint Patterns Monoarticular Trauma, hemarthrosis, spondyloarthropathy Septic arthritis, crystal-induced Oligoarticular Spondyloarthropathy, crystal-induced, infection related Polyarticular RA, SLE, crystal-induced, infectious 4
5 Rheum Diseases You Will Encounter Osteoarthritis Rheumatoid Arthritis Seronegative spondyloarthropathy Crystal-induced arthritis Systemic lupus erythematosus Vasculitis Other important rheumatologic diseases Scleroderma, Inflammatory Myopathy 5
6 OSTEOARTHRITIS Most common form of arthritis > 50 years of age Risk factors: age, obesity, occupation, history of trauma Most common sites: hands, feet, knees, hips, AC joints, and facet joints of the cervical and lumbosacral spine PAIN (mechanical type), stiffness (< 30 minutes) Non-inflammatory, no systemic involvement DIP/PIP involvement; spares the wrists (Heberden s/ Bouchard s)
7 OSTEOARTHRITIS Bouchard s and Heberden s nodes
8 7/18/2018 Template copyright
9 Treatment Minimize risk factors Physical therapy Analgesic medications NSAIDs Tylenol, Tramadol Periodic steroid injection in selected cases Joint replacement in advanced cases
10 RHEUMATOID ARTHRITIS Chronic (>6 wks), inflammatory Female > Male AM stiffness lasting at least 1 hr Typically involves wrist, MCP, or PIP joints Polyarticular and symmetric Swan neck/boutonniere/ulnar deviation Extra-articular manifestations Rheumatoid nodules, interstitial lung disease, vasculitis
11 Diagnostic Criteria: Rheumatoid Arthritis Target population At least 1 joint with definite synovitis Synovitis not better explained by another disease Score of >/= 6/10 needed Joints 1 large (0), 2-10 large (1), 1-3 small (2), 4-10 small (3) >10 joints including at least 1 small (5) Serology (at least 1 test result needed) Negative RF and CCP (0), Low positive RF or CCP (2) high positive RF or CCP (3) Acute phase reactants (at least 1 test needed) Normal CRP and ESR (0), abnormal CRP or ESR (1) Duration of symptoms < 6 wks (0) > 6 wks (1)
12 RHEUMATOID ARTHRITIS
13 7/18/2018 Template copyright
14 RHEUMATOID ARTHRITIS
15 7/18/2018 Template copyright
16 Treatment Short term: prednisone Mild disease: NSAIDs, hydroxychloroquine, sulfasalazine Moderate to severe: Oral weekly methotrexate, leflunomide (alternative to methotrexate) anti-tnf agents Adalimumab, Etanercept, Infliximab (IV), et al CTLA4 agonist (inhibit T cell co-stimulatory process Abatacept anti-cd20 (B cells) Rituximab anti-il1 Anakinra anti-il6 Tocilizumab
17 Seronegative Spondyloarthropathy Seronegative Oligoarticular, asymmetric Chronic, inflammatory Sacroiliac involvement Enthesopathy Spinal involvement (inflammatory) HLA B27 17
18 Seronegative Spondyloarthropathies Ankylosing spondylitis IBD associated arthropathy Psoriatic arthritis Reactive arthritis Undifferentiated spondyloarthropathy 18
19 Treatment Similar to treatment for rheumatoid arthritis 3 differences Hydroxychloroquine can worsen psoriasis Axial involvement Biologic therapy recommended TNF alpha inhibitors are mainstay for biologics (the other biologics not shown to be as effective)
20 Chronic inflammatory disorder Main symptom is inflammatory back pain Affects the axial spine, entheses, peripheral joints and eyes Prevalence 0.5% Etiology unknown Genetic predisposition associated with HLA B27 Symptoms begin in 20 s Commonly seen in caucasian men 7/18/
21 7/18/2018 Template copyright
22 7/18/2018 Template copyright
23 Psoriatic Arthritis 7/18/2018 Template copyright
24 Dactylitis (Sausage Toes)
25 Onycholysis (Psoriasis)
26 ACUTE GOUT
27 GOUT Recurrent, episodic inflammatory arthritis Peak of pain: 24 hours; subside in 3-10 days 75 % of initial attacks in 1 st MTP joint (podagra) Usually monoarticular, may be polyarticular Hyperuricemia may or may not be present (normal or low in up to 30% patients with acute attack) Predisposing factors and associated conditions: surgery, medications (DIURETICS, low dose aspirin, cyclosporine A), alcohol ingestion, hypertension, renal insufficiency, hyperlipidemia
28 Gout (diagnosis)
29 Chronic Tophaceous Gout
30 Chronic Tophaceous Gout 7/18/2018 Template copyright
31 Chronic Tophaceous Gout 7/18/2018 Template copyright
32 Chronic Tophaceous Gout 7/18/2018 Template copyright
33 Treatment Gout Acute NSAIDs (ibuprofen, indocin, naproxen), Colchicine, Steroids (prednisone), steroid injection if appropriate, anakinra Long term (2 or more attacks/year, tophi, erosions) allopurinol, febuxostat, probenecid Prophylaxis Colchicine, low dose prednisone, or NSAIDs (up to 6 months) Pseudogout Acute same as above Long term N/A, methotrexate in refractory cases
34 Systemic Lupus Erythematosus Young women, multisystemic disease Malar Rash Discoid Rash Serositis Oral ulcers Arthritis Photosensitivity Blood disorder Renal disorder ANA* Immunologic abnormalities (anti-smith antibody, antidouble stranded DNA, antiphospholipid antibodies) Neurologic symptoms 34
35 SYSTEMIC LUPUS ERYTHEMATOUS (MALAR RASH)
36 Discoid Lupus
37 Treatment Short term: prednisone Mild or cutaneous disease Hydroxychloroquine Moderate to severe disease Azathioprine, Mycophenolate mofetil Severe disease Mycophenolate mofetil Rituximab Cyclophosphamide
38 Scleroderma Localized vs Systemic Systemic : Diffuse or Limited Limited = CREST (Calcinosis, Raynaud s, Esophageal dysmotility, Sclerodactyly, Telangiectasias) Limited Skin involvement distal to MCPs Lung complication: Primary pulmonary hypertension More esophageal involvement, less colon involvement, telangiectasias Anti-Centromere antibodies Diffuse Lung complication: Interstitial lung disease/fibrosis Diffuse Scl GI complications ie) colon involvement more common Scl 70 Antibodies Scleroderma renal crisis can occur in both 38
39 SCLERODERMA
40 SCLERODERMA 7/18/2018 Template copyright
41 RAYNAUD S PHENOMENON
42 SCLERODERMA-GAVE 7/18/2018 Template copyright
43 SCLERODERMA-LUNG 7/18/2018 Template copyright
44 Treatment No single medication for all manifestations of scleroderma Treat each manifestation GERD: Proton pump inhibitors Raynaud s: calcium channel blockers (nifedipine), losartan, sildenafil Pulmonary hypertension: sildenafil, calcium channel blocker Interstitial lung disease: mycophenolate mofetil, azathioprine Scleroderma renal crisis: ACE inhibitor
45 Vasculitis Inflammation & necrosis of blood vessel Perforation & hemorrhage, thrombosis, ischemia 45
46 Vasculitis 7/18/2018 Template copyright
47 7/18/2018 Template copyright
48 GIANT CELL ARTERITIS
49 Giant Cell Arteritis Patients >50 y/o Cranial symptoms superficial HA, scalp tenderness, jaw claudication, blindness Polymyalgia rheumatica pain and stiffness of proximal joints Fever, systemic symptoms Decreased temporal artery pulse Elevated ESR and CRP Diagnosis: Biopsy of temporal artery 49
50 Idiopathic Inflammatory Myopathy Polymyositis Dermatomyositis PM and DM Proximal muscle weakness Muscle pain not a typical symptom if chronic Elevated muscle enzymes: CK, Aldolase, LDH Myositis Panel Diagnosis: biopsy Lung involvement: interstitial lung disease Increased risk for malignancy: breast cancer, ovarian cancer, adenocarcinoma 50
51 DERMATOMYOSITIS
52 DERMATOMYOSITIS 7/18/2018 Template copyright
53 DERMATOMYOSITIS 7/18/2018 Template copyright
54 DERMATOMYOSITIS 7/18/2018 Template copyright
55 DERMATOMYOSITIS 7/18/2018 Template copyright
56 DERMATOMYOSITIS 7/18/2018 Template copyright
57 DERMATOMYOSITIS 7/18/2018 Template copyright
58 Treatment Steroids, high dose prednisone followed by taper Steroid sparing agents Methotrexate, azathioprine Interstitial lung disease Mycophenolate, azathioprine Cutaneous manifestations Hydroxychloroquine
Objectives. Joint Pain. Case 1. Rheumatology for the Primary MD (Not just your grandmother s disease) 12/4/2010
Objectives Rheumatology for the Primary MD (Not just your grandmother s disease) Identify when it is appropriate to refer for rheumatologic evaluation Autoimmune/ Inflammatory v. noninflammatory disease
Jeopardy. What s the rash? $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400
Jeopardy Antibodies & more antibodies Aching joints What s the rash? Potpourri Image Challenge $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400 $500 $500
Patient #1. Rheumatoid Arthritis. Rheumatoid Arthritis. 45 y/o female Morning stiffness in her joints >1 hour
Patient #1 Rheumatoid Arthritis Essentials For The Family Medicine Physician 45 y/o female Morning stiffness in her joints >1 hour Hands, Wrists, Knees, Ankles, Feet Polyarticular, symmetrical swelling
Index. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abatacept, for rheumatoid arthritis, 789 Acetaminophen, for low back pain, 735 Acupuncture for fibromyalgia, 753 for low back pain, 738
Coverage Criteria: Express Scripts, Inc. monograph dated 12/15/ months or as otherwise noted by indication
BENEFIT DESCRIPTION AND LIMITATIONS OF COVERAGE ITEM: PRODUCT LINES: COVERED UNDER: DESCRIPTION: CPT/HCPCS Code: Company Supplying: Setting: Kineret (anakinra subcutaneous injection) Commercial HMO/PPO/CDHP
JuvenileIdiopathicArthritis. Dr Johan Siebert
JuvenileIdiopathicArthritis Dr Johan Siebert 1 NORMAL DIARTHRODIAL JOINT Synovial is a thin membrane enclosing the joint space The joint space contains fluid that bathes the joint and reduces friction
Seronegative Arthritis. Dr Mary Gayed 25 th April 2018
Seronegative Arthritis Dr Mary Gayed 25 th April 2018 Overview Description of the conditions Discussion of symptoms & investigations that may be required Discussion of management and treatment Questions
APPROACH TO PATIENTS WITH POLYARTHRALGIA
APPROACH TO PATIENTS WITH POLYARTHRALGIA Scott Vogelgesang, MD Division of Immunology University of Iowa No conflicts of interest DEFINITIONS Arthralgia joint pain with no evidence of inflammation Arthritis
Kelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition
Kelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition Firestein, G ISBN-13: 9781437717389 Table of Contents VOLUME I STRUCTURE AND FUNCTION OF BONE,
Essential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT
Essential Rheumatology Dr Ellen Bruce Consultant Rheumatologist CMFT Saving the best for last! Apparently people recall best the first and last thing they re told. Far too difficult to include everything.
Rheumatoid Arthritis. Marge Beckman FALU, FLMI Vice President RGA Underwriting Quarterly Underwriting Meeting March 24, 2011
Rheumatoid Arthritis Marge Beckman FALU, FLMI Vice President RGA Underwriting Quarterly Underwriting Meeting March 24, 2011 The security of experience. The power of innovation. www.rgare.com Case Study
A CRP B FBC C LFT D blood culture E uric acid
1 A 39 year old lady with rheumatoid arthritis is admitted to hospital with a hot, swollen and painful right knee. Which is the most important blood test? A CRP B FBC C LFT D blood culture E uric acid
Rheumatoid arthritis and Psoriatic arthritis: a guide for Primary Care. Nina Flavin, MD Rheumatology Confluence Health April 13 th, 2018
Rheumatoid arthritis and Psoriatic arthritis: a guide for Primary Care Nina Flavin, MD Rheumatology Confluence Health April 13 th, 2018 No Disclosures Objectives Recognize early signs of RA/PsA what to
Osteoarthritis. Rheumatology Update. Gout 1/17/2013
Osteoarthritis Rheumatology Update Richard Zweig, MD January, 2013 Degeneration of cartilage over time accompanied by increase in bone density and bone formation around the joint Risks include: aging,
Rheumatology Review Update in Internal Medicine COPYRIGHT. Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center.
Rheumatology Review Update in Internal Medicine Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center Boston MA Case #1 True statement(s) regarding etanercept and leflunomide, for the treatment
How do polyarthritis, polyarthralgias, and diffuse aches and pains differ?
Approach to the patient with polyarthritis How do polyarthritis, polyarthralgias, and diffuse aches and pains differ? Polyarthritis is definite inflammation (swelling, tenderness, warmth) of more than
Learning Objectives and Assessment Methodologies Combined Medicine-Pediatrics Rheumatology Elective
Learning Objectives and Assessment Methodologies Combined Medicine-Pediatrics Rheumatology Elective Overview: Med-Peds PGY2 s, PGY3 s and PGY4 s can elect to spend one four-week rotation with the adult
2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.
Making Room for Rheumatology James J. Nocton, MD Disclosures I have nothing to disclose Rheumatic Diseases of Childhood Juvenile Idiopathic Arthritis (JIA) Systemic Lupus Erythematosus (SLE) Juvenile Dermatomyositis
Is it Autoimmune or NOT! Presented to AONP! October 2015!
Is it Autoimmune or NOT! Presented to AONP! October 2015! Four main jobs of immune system Detects Contains and eliminates Self regulates Protects Innate Immune System! Epithelial cells, phagocytic cells
Dr Oseme Etomi and Dr Arabella Waller SpRs in Rheumatology Barts and the London
Dr Oseme Etomi and Dr Arabella Waller SpRs in Rheumatology Barts and the London Contents Monoarthropathies Polyarthropathies Inflammatory back pain Connective tissue disease and myositis Vasculitis Some
Rheumatology Cases for the Internist
Rheumatology Cases for the Internist Marc C. Hochberg, MD, MPH Professor of Medicine Head, Division of Rheumatology and Clinical Immunology Vice Chair, Department of Medicine University of Maryland School
Rheumatologic Manifestations of Gastrointestinal Diseases
Rheumatologic Manifestations of Gastrointestinal Diseases NATASHA DEHGHAN, MD, FRCPC CLINICAL ASSISTANT PROFESSOR VASCULITIS CLINIC, MARY PACK ARTHRITIS CENTRE Objectives To discuss a few common rheumatologic
Rheumatologic Laboratory Testing and Common Hematological Drugs. September 10, 2013 Dr. Jeffrey C. Hoschek, MD, FAAP
Rheumatologic Laboratory Testing and Common Hematological Drugs September 10, 2013 Dr. Jeffrey C. Hoschek, MD, FAAP THERE ARE MULTIPLE TESTS USED TO BOTH SCREEN FOR AND MAKE THE DIAGNOSIS OF MANY RHEUMATOLOGICAL
1. To review the diagnosis of gout and its differential. 2. To understand the four stages of gout
Objectives 1. To review the diagnosis of gout and its differential GOUT 2. To understand the four stages of gout 3. To develop an approach for the acute treatment of gout Anthony Lim 9/13/12 Cycle 3 4.
First Presentation of Joint Pain
First Presentation of Joint Pain Andrew Harrison Rheumatologist Wellington Regional Rheumatology Unit, HVDHB Bowen Centre, Crofton Downs, Wellington Assoc. Prof. in Medicine, University of Otago Wellington
Rheumatology Primer: What Labs and When
Rheumatology Primer: What Labs and When Irina Konon, MD Department of Internal Medicine Division of Rheumatology Medical College of Wisconsin Disclosures None 1 Objective Discuss principles of laboratory
REFERRAL GUIDELINES: RHEUMATOLOGY
Outpatient Page 1 1 REFERRAL GUIDELINES: RHEUMATOLOGY Date of birth Demographic Contact details (including mobile phone) Clinical Reason for referral Duration of symptoms Essential Referral Content Referring
DEPARTMENT OF RHEUMATOLOGY
DEPARTMENT OF RHEUMATOLOGY PG Teaching Schedule Theory (8 30 am to 9am) DATE TOPIC PRESENTER FACULTY 01/10/16 Approach to Arthritis Dr. Sandeep Dr. Suma Balan 03/10/16 Cardiovascular risk in Rheumatic
Rheumatoid arthritis
Rheumatoid arthritis 1 Definition Rheumatoid arthritis is one of the most common inflammatory disorders affecting the population worldwide. It is a systemic inflammatory disease which affects not only
Case Based Rheumatology STEVE S LEE, DO FACR SCPMG FONTANA
Case Based Rheumatology STEVE S LEE, DO FACR SCPMG FONTANA Disclosure Clinical Investigator: EMD Serono Amgen Roche 1 Learning Objectives Crystalline arthropathy GCA/PMR Infectious arthritis Connective
Rheumatoid Arthritis. By: Hadi Esmaily (PharmD., BCCP, MBA) Department of Clinical Pharmacy, Shahid Beheshti Medical University
Rheumatoid Arthritis By: Hadi Esmaily (PharmD., BCCP, MBA) Department of Clinical Pharmacy, Shahid Beheshti Medical University Introduction RA is a Chronic, Systemic, Inflammatory disorder of unknown etiology
ACP Rheumatology Pearls. Adam Q Carlson MD Assistant Professor UVA Rheumatology
ACP Rheumatology Pearls Adam Q Carlson MD Assistant Professor UVA Rheumatology Disclosures I have no personal or professional disclosures Case #1 27 yo woman with a history of systemic lupus complicated
Effective management of arthritis. Gail Dolan Victoria ACH Liz McIvor Stobhill ACH
Effective management of arthritis Gail Dolan Victoria ACH Liz McIvor Stobhill ACH Role Types of arthritis Drugs Self Management Role Of CNS Advanced level nurses offering specialist care in a specific
When is it Rheumatoid Arthritis When to Refer
When is it Rheumatoid Arthritis When to Refer Nancy A. Brown, DO Spring 2015 When is it Rheumatoid Arthritis When to Refer Learning objectives To review the definition and epidemiology of Rheumatoid Arthritis
Rheumatology Updates for the Primary Care Provider
Rheumatology Updates for the Primary Care Provider Jean Tayar, MD, RhMSUS Associate Professor Section of Rheumatology and Clinical Immunology Department of General Internal Medicine UT MD Anderson Cancer
Dr David Porter. Rheumatologist/General Physician Nelson
Dr David Porter Rheumatologist/General Physician Nelson 4 th Annual South Island GP CME Perhaps the most critical issue in the initial assessment of a patient presenting with symptoms of arthritis is to
Manifestations and Presentations of Collagen Vascular Diseases. Joseph LaConti, M.D., Ph.D. Center for Arthritis and Rheumatic Diseases Miami, FL
Manifestations and Presentations of Collagen Vascular Diseases Joseph LaConti, M.D., Ph.D. Center for Arthritis and Rheumatic Diseases Miami, FL June 29, 2018 Disclosures Joseph LaConti, M.D., Ph.D., has
Undifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD
Undifferentiated Connective Tissue Disease and Overlap Syndromes Mark S. Box, MD Overlap Syndromes As many as 25% of patients with rheumatic diseases with systemic symptoms cannot be definitely diagnosed
Juvenile Idiopathic Arthritis (JIA)
Juvenile Idiopathic Arthritis (JIA) Kaveh Ardalan, MD, MS Division of Rheumatology Ann & Robert H. Lurie Children s Hospital of Chicago Assistant Professor, Pediatrics and Medical Social Sciences Northwestern
Introduction. Rheumatoid Arthritis. Rheumatoid Arthritis. Arthritis vs Rheumatoid Arthritis
Rheumatoid Arthritis Stuart Weisman, MD Boulder Medical Center, P.C. 303-622-3724 Introduction What is rheumatoid arthritis? How is it different than arthritis? What are the symptoms? How is it diagnosed?
What organ system is involved? What is the pathology? What is the possible etiology?
Johan van Rensburg What organ system is involved? What is the pathology? What is the possible etiology? Genetic Environmental What are the possible complications? How is the patient s functioning impaired?
Regulatory Status FDA- approved indication: Simponi and Simponi ARIA are tumor necrosis factor (TNF) blockers indicated for the treatment of: (2-3)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.51 Subject: Simponi / Simponi ARIA Page: 1 of 9 Last Review Date: March 16, 2018 Simponi / Simponi
Ad-Hoc Rheumatology Subcommittee of PTAC meeting held 8 March. (minutes for web publishing)
Ad-Hoc Rheumatology Subcommittee of PTAC meeting held 8 March 2011 (minutes for web publishing) Ad-Hoc Rheumatology Subcommittee minutes are published in accordance with the Terms of Reference for the
Dr David Porter. Rheumatologist & General Physician Nelson Marlborough DHB
Dr David Porter Rheumatologist & General Physician Nelson Marlborough DHB GENERAL PRACTICE SEMINAR - Rotorua David Porter 2 Perhaps the most critical issue in the initial assessment of a patient presenting
Rheumatology 101 A Pediatrician s Guide
Rheumatology 101 A Pediatrician s Guide Pediatric Staff and Alumni Day 2016 Dawn M. Wahezi, Yonit Sterba, Tamar Rubinstein Disclosures None Pick a Group Group 1 A child with a limp Group 2 ANA To test
Rheumatology Potpourri. Dr. Philip A. Baer Seacourses Asia CME December 2017
Rheumatology Potpourri Dr. Philip A. Baer Seacourses Asia CME December 2017 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted
Medical Management of Rheumatoid Arthritis (RA)
Medical Management of Rheumatoid Arthritis (RA) Dr Lee-Suan Teh Rheumatologist Royal Blackburn Hospital Educational objectives ABC Appreciate the epidemiology of RA Be able to diagnosis of RA Competent
Family Medicine Board Review 2015
Overview of Today s Review (At least that which can be covered in one hour) Family Medicine Board Review 2015 Rheumatology Section Jonathan Graf, M.D. Associate Professor of Clinical Medicine, UCSF Division
Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None
Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies Sarah Goglin MD Assistant Professor of Medicine Division of Rheumatology Disclosures None 1 [footer
The Johns Hopkins Hospital
The Johns Hopkins Hospital 19901006 2016/03/21-04/20 (rheumatology) (emergecny medicine) (rheumatology consult team) attending Dr. Haque, R2 Dr. Michailidou, fellow Dr. Adler "She is a so interesting case.
High Impact Rheumatology
High Impact Rheumatology Systemic Lupus Erythematosus Bernard Rubin, DO MPH Case 1: History A 45-year-old woman presents with severe dyspnea and cough. She was in excellent health until 4 weeks ago when
Differential Diagnosis of Polyarthritis/Polyarthralgia
Differential Diagnosis of Polyarthritis/Polyarthralgia Robert P. Friday, M.D., Ph.D. Newton-Wellesley Hospital Rheumatology Mass General Hospital Rheumatology None. Disclosures Polyarthritis Outline 1.
Differential Diagnosis of Polyarthritis/Polyarthralgia
Differential Diagnosis of Polyarthritis/Polyarthralgia Robert P. Friday, M.D., Ph.D. Newton-Wellesley Hospital Rheumatology Mass General Hospital Rheumatology None. Disclosures Polyarthritis Outline 1.
Rheumatoid Arthritis
Rheumatoid Arthritis What is rheumatoid arthritis? Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation of the joints. Rheumatoid arthritis can also cause inflammation of
The Joints are Painful & Swollen: Do I give Steroids? Dr Tom Kennedy
The Joints are Painful & Swollen: Do I give Steroids? Dr Tom Kennedy Learning Objectives When to use an acute rheumatology service Appropriate use of steroids by condition Injection or Oral or Intramuscular
Rheumatoid arthritis, seronegative spondylarthritides and gout. György Nagy
Rheumatoid arthritis, seronegative spondylarthritides and gout György Nagy Dec 4, 2017 Rheumatoid arthritis Rheumatoid arthritis Chronic, progressive, autoimmune disorder of the joints with extra-articular
Rheumatologic Emergencies It s not just swollen joints. Joanne Homik Rheumatologist University of Alberta
Rheumatologic Emergencies It s not just swollen joints Joanne Homik Rheumatologist University of Alberta Or is it? Disclosures No relevant conflicts of interest regarding the content of this presentation
Systemic forms of stiffness
Systemic forms of stiffness ANNA LITWIC CONSULTANT RHEUMATOLOGIST SALISBURY DISTRICT HOSPITAL CLINICAL RESEARCH FELLOW MRC LIFECOURSE EPIDEMIOLOGY UNIT Overview Rheumatoid arthritis Know it when you see
Mary Derlacki, FNP. No financial relationships to disclose. Office Rheumatology for the Nurse Practitioner. Rheumatoid Arthritis
Office Rheumatology for the Nurse Practitioner Mary Derlacki, FNP Drs. Cassell and Boren Eugene, OR 541-687-0816 mderlacki@comcast.net No financial relationships to disclose Rheumatoid Arthritis 1% of
Etiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis
Etiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis JIA is the most common rheumatic disease in childhood and a major cause of chronic disability. Etiology: Unknown, but may
www.fisiokinesiterapia.biz Peak onset between 20 and 30 years Form of spondyloarthritis (cause inflammation around site of ligament insertion into bone) and association with HLA-B27 Prevalence as high
EARLY INFLAMMATORY ARTHRITIS. Cristina Tacu Consultant Rheumatologist Brighton and Sussex University Hospital
EARLY INFLAMMATORY ARTHRITIS Cristina Tacu Consultant Rheumatologist Brighton and Sussex University Hospital EIA: Introduction National priority Preventable cause of disability Very common condition High
Disclosures. Goals. Rheumatology Review for Primary Care. No commercial disclosures. We will be discussing non-fda approved uses for some medications.
Rheumatology Review for Primary Care April 27, 2018 MONA Coming Together in Advanced Practice Disclosures No commercial disclosures. We will be discussing non-fda approved uses for some medications. Goals
Family Medicine Board Review Rheumatology Section Jonathan Graf, M.D. Professor of Clinical Medicine, UCSF Division of Rheumatology ZSFGH
Family Medicine Board Review 2017 Rheumatology Section Jonathan Graf, M.D. Professor of Clinical Medicine, UCSF Division of Rheumatology ZSFGH Overview of Today s Review (At least that which can be covered
Rheumatology for the Nurse Practitioner. Mary Derlacki, FNP Eugene Rheumatology
Rheumatology for the Nurse Practitioner Mary Derlacki, FNP Eugene Rheumatology Financial Relationships Amgen Genentech AbbVie IS THIS LUPUS? S.T. is a 45 y/o woman with 9 months of joint pain, fatigue,
Family Medicine Board Review 2013
Overview of Today s Review (At least that which can be covered in one hour) Family Medicine Board Review 2013 Rheumatology Section Jonathan Graf, M.D. Associate Professor of Clinical Medicine, UCSF Division
Review Article. Appraoch to Patients with Polyarticular Symptoms. Introduction. Raymond WS Wong
Review Article Appraoch to Patients with Polyarticular Symptoms Raymond WS Wong Abstract: Keywords: Polyarticular symptoms represent the most common symptom complex resulting in referral to a rheumatologist
Department of Paediatrics Clinical Guideline
Department of Paediatrics Clinical Guideline The child and young person with possible arthritis (joint swelling and/or pain, loss of function for >4 weeks) Definition: Juvenile Idiopathic Arthritis (JIA)
Family Medicine Board Review Rheumatology Section Jonathan Graf, M.D. Professor of Clinical Medicine, UCSF Division of Rheumatology ZSFGH
Family Medicine Board Review 2018 Rheumatology Section Jonathan Graf, M.D. Professor of Clinical Medicine, UCSF Division of Rheumatology ZSFGH Overview of Today s Review (At least that which can be covered
Rheumatoid Arthritis Marginal erosions (mid-late) Peri-articular osteoporosis (earlyonward)
Family Medicine Board Review 2008 Rheumatology Section Jonathan Graf, M.D. Assistant Professor of Medicine, UCSF Division of Rheumatology SFGH Overview of Today s Review (At least that which can be covered
Department of Paediatrics Clinical Guideline. Guideline for the child with possible arthritis (joint swelling/pain, loss of function)
Department of Paediatrics Clinical Guideline Guideline for the child with possible arthritis (joint swelling/pain, loss of function) Definition: Juvenile Idiopathic Arthritis (JIA) is defined as arthritis
TABLE OF CONTENTS. Contents
TABLE OF CONTENTS Contents TABLE OF CONTENTS This media guide was created by the American College of Rheumatology and is designed to be used as a reference by members of the media who are reporting on
Myositis and Your Lungs
Myositis and Your Lungs 2013 TMA Annual Patient Meeting Louisville, Kentucky Chester V. Oddis, MD University of Pittsburgh Director, Myositis Center Myositis Heterogeneous group of autoimmune syndromes
Regulatory Status FDA- approved indication: Simponi and Simponi ARIA are tumor necrosis factor (TNF) blockers indicated for the treatment of:
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.51 Subject: Simponi / Simponi ARIA Page: 1 of 8 Last Review Date: March 17, 2017 Simponi / Simponi
Rhematologic serum testing is: Before request serologic tests, ANCA associated antigens c-anca: most commonly against the proteinase 3 (PR-3)
thorough P/E. Rhematologic serum testing is: Useful to confirm a clinical impression or sort out a differential diagnosis Not useful as a screening test A positive test may or may not be associated with
Inflammatory rheumatic diseases
Learning objectives Inflammatory rheumatic diseases Bruce Kidd Barts & The London, Queen Mary, University of London To understand: 1. prevalence and range of the rheumatological s 2. clinical features
Crystal induced arthropathies. Dr. Amitesh Aggarwal
Crystal induced arthropathies Dr. Amitesh Aggarwal 1 Crystal induced Arthropathies Gout Pseudogout Debilitating illnesses; Recurrent episodes of pain and joint inflammation; Formation and deposition of
Rheumatoid Arthritis. Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904)
Rheumatoid Arthritis Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904) 503-6999. 1 Disclosures Speaker Bureau: Abbvie 2 Objectives Better understand the pathophysiology
Patient with Musculo-skeletal Complaints - Summary
Patient with Musculo-skeletal Complaints - Summary 1. Soft Tissue Rheumatism or Arthritis 2. Arthritis Monoarticular Polyarticular - :- (Asymmetrical) (Symetrical) :- -Crystals, Gout - Infective acute
JIA and Other Rheumatic Diseases in Children. Norma Liburd, RN-BC, MN
JIA and Other Rheumatic Diseases in Children Norma Liburd, RN-BC, MN Define Juvenile Idiopathic Arthritis (JIA) and discuss the diagnostic criteria. Objectives Identify the subtypes of JIA and discuss
Pediatric Rheumatology: A Case-based Approach to the Basics. Hilary M. Haftel, MD, MHPE University of Michigan Department of Pediatrics
Pediatric Rheumatology: A Case-based Approach to the Basics Hilary M. Haftel, MD, MHPE University of Michigan Department of Pediatrics Disclosures I have no relevant financial relationships with the manufacturer(s)
Development of SLE among Possible SLE Patients Seen in Consultation: Long-Term Follow-Up. Disclosures. Background. Evidence-Based Medicine.
Development of SLE among Patients Seen in Consultation: Long-Term Follow-Up Abstract # 1699 May Al Daabil, MD Bonnie L. Bermas, MD Alexander Fine Hsun Tsao Patricia Ho Joseph F. Merola, MD Peter H. Schur,
Gout 2.0. Scott Vogelgesang, M.D. Division of Immunology: Rheumatology & Allergy
Gout 2.0 Scott Vogelgesang, M.D. Division of Immunology: Rheumatology & Allergy Case 48 year old man presents with swollen, painful left toe that started overnight. Didn t hurt when he went to bed. No
Test Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091593 Age 25 Years Gender Male 30/8/2017 91600AM 30/8/2017 93946AM 31/8/2017 84826AM Ref By Final COLLAGEN DISEASES ANTIBODY ANEL ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF),
Articular disease of the hand - the target joint approach
Articular disease of the hand - the target joint approach Poster No.: C-1817 Congress: ECR 2016 Type: Educational Exhibit Authors: R. R. Domingues Madaleno 1, A. P. Pissarra 1, I. Abreu 2, A. Canelas 1,
Autoimmune diseases. SLIDE 3: Introduction to autoimmune diseases Chronic
SLIDE 3: Introduction to autoimmune diseases Chronic Autoimmune diseases Sometimes relapsing : and remitting. which means that they present as attacks Progressive damage Epitope spreading more and more
Overview of Paediatric Investigation Plan (PIP) in Paediatric Rheumatology
Overview of Paediatric Investigation Plan (PIP) in Paediatric Rheumatology Paediatric Rheumatology Expert Meeting, London 4 th December 29 Dr. Richard Veselý, Dr. Emma Sala Soriano Paediatric Investigation
New Onset Arthritis. Clinical Dilemmas in Arthritis and Rheumatology. Physical Examination. Other Pertinent History
New Onset Arthritis Clinical Dilemmas in Arthritis and Rheumatology Primary Care Principles and Practice October 2008 Jonathan Graf, MD Assistant Professor of Medicine, UCSF Division of Rheumatology, SFGH
Gout -revisited. Shrenik Shah
Gout -revisited Shrenik Shah definition Monosodium urate (MSU) crystal deposition episodic and later persistent joint inflammation and tophi All MSU crystal deposition- broader definition EULAR- European
Rheumatology: 1. Is it arthritis?
Clinical basics Rheumatology: 1. Is it arthritis? Stephanie Ensworth Case 1 A 29-year-old woman consults her physician 2 months after the birth of her second child because she woke one morning with pain
Rheumatology ACP Puerto Rico Chapter Meeting March 8-10, 2019
Rheumatology ACP Puerto Rico Chapter Meeting March 8-10, 2019 Elena Myasoedova, MD, PhD Assistant Professor of Medicine Mayo Clinic Rochester, Minnesota myasoedova.elena@mayo.edu 2017 MFMER slide-1 Disclosures
Scleroderma. Nomenclature Synonyms. Scleroderma. Progressive Systemic Sclerosis. Systemic Sclerosis. Edward Dwyer, M.D. Division of Rheumatology
Scleroderma Edward Dwyer, M.D. Division of Rheumatology Nomenclature Synonyms Scleroderma Progressive Systemic Sclerosis Systemic Sclerosis Scleroderma 1 Scleroderma Chronic systemic autoimmune disease
Scleroderma. Nomenclature Synonyms. Scleroderma. Progressive Systemic Sclerosis. Systemic Sclerosis. Limited vs. Diffuse Scleroderma.
Scleroderma Edward Dwyer, M.D. Division of Rheumatology Nomenclature Synonyms Scleroderma Progressive Systemic Sclerosis Systemic Sclerosis Scleroderma Chronic systemic autoimmune disease characterized
THE MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS
THE MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS Prof Chris Scott PAEDIATRIC RHEUMATOLOGIST UNIVERSITY OF CAPE TOWN RED CROSS WAR MEMORIAL CHILDRENS S HOSPITAL Chronic Arthritis >6wks JIA No other cause
Subject: Remicade (Page 1 of 5)
Subject: Remicade (Page 1 of 5) Objective: I. To ensure that Health Share/Tuality Health Alliance (THA) has a process by which the appropriate utilization of Remicade (Infliximab) for members whose diagnosis
Juvenile Chronic Arthritis
Juvenile Chronic Arthritis Dr. Christa Visser MBChB MMed (Med Phys) Diploma Musculoskeletal Medicine (UK), Member Society of Orthopaedic Medicine (UK) Childhood Arthritis JCA/JIA/JRA Remember Acute rheumatic
4 2 Osteoarthritis 1
Osteoarthritis 1 Osteoarthritis ( OA) Osteoarthritis is a chronic disease and the most common of all rheumatological disorders. It particularly affects individuals over the age of 65 years. The prevalence
LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS LUPUS 101 SLE SUBSETS AUTOIMMUNE DISEASE 11/4/2013 HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS
LUPUS 101 LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS SLE SUBSETS SUBACUTE CUTANEOUS LUPUS DRUG INDUCED LUPUS NEONATAL LUPUS LATE ONSET LUPUS ANTI-PHOSPHOLIPID